Nordstrom’s (JWN) Q4 performance is expected to have gained from brand strength, digital momentum and a solid performance in the Nordstrom banner. Supply-chain woes are likely to have hurt.
Category archives: Stocks
United Therapeutics (UTHR) Q4 Earnings & Sales Miss, Stock Down
United Therapeutics (UTHR) fourth-quarter earnings and sales miss estimates. Higher sales of Tyvaso and Unituxin mainly drive the top line in the quarter, offset by lower sales of other drugs.
Cohen & Steers (CNS) Rewards Shareholders With Dividend Hike
Cohen & Steers (CNS) announces a quarterly dividend of 55 cents per share, representing a hike of 22.2% from the prior payout of 45 cents.
2 Best Waste Management Stocks to Own in 2022: Clean Harbors and Heritage-Crystal Clean
The need for advanced waste management has garnered immense attention from big market players amid increasing ESG investment trends. The sector is necessary to achieve sustainable growth. Thus, we think…
3 Stocks to Avoid due to Supply Chain Issues: Toyota, Weber, and Lam Research
Industrial supply chain disruptions have persisted over the past year, owing to sky-high demand, labor shortages, and increased market uncertainty. And these supply risks are expected to flare up in…
Flowserve (FLS) Q4 Earnings & Revenues Miss Estimates, Down Y/Y
Flowserve’s (FLS) fourth-quarter 2021 revenues decrease 6.7% year over year on lackluster performance across most of its segments.
Will Lucid’s (LCID) Q4 Earnings Upset Investors Once Again?
The Zacks Consensus Estimate for Lucid’s (LCID) Q4 bottom line is pegged at a loss of 26 cents per share.
Company News for Feb 25, 2022
Companies in The News Are: AEP,ATHM,IONS,DISH
Is Gran Tierra Energy a Good Oil & Gas Stock to Own in 2022?
The stock of Canadian oil and gas producer Gran Tierra Energy (GTE) has been surging in price, driven primarily by the relentless oil price rally. Oil prices are soaring, underpinned…
Intellia (NTLA) Q4 Loss Wider Than Expected, Revenues Up Y/Y
Intellia Therapeutics (NTLA) reports wider-than-expected Q4 loss. Nonetheless, revenues beat estimates.